The advisory meeting is scheduled for 24 July 2026, so the proposal was not a final FDA determination when this article was reviewed
The Gila monster inspired drugs like tirzepatide as its venom contains hormones that can regulate blood sugar and impact appetite
Laboratory research record on GLP-1S [PMID: 36599459] PubMed laboratory record discussing GLP-1S in a research context
SGLT2 inhibitors and cardiovascular and renal outcomes: a meta-analysis and trial sequential analysis
While the addition of DCA did not produce a statistically significant improvement in clinical outcomes compared to historical controls, the study confirmed the feasibility of integrating metabolic-targeting agents with conventional therapy in HNSCC and provided a rationale for further investigation in selected patient populations (247)
Kreuzer PM, Landgrebe M, Vielsmeier V, Kleinjung T, De Ridder D, Langguth B